Nikhil Pharma Agencies

Noveltreat 1.7 mg (semaglutide) is a weekly, prescription-only injection used primarily for long-term weight management in adults and adolescents (12+) with obesity or overweight, often used alongside reduced-calorie diets and exercise. It also helps manage type 2 diabetes by controlling blood sugar and reducing cardiovascular risks.

Noveltreat 0.5 mg (semaglutide) is a weekly, prescription-only injection used primarily for long-term weight management in adults and adolescents (12+) with obesity or overweight, often used alongside reduced-calorie diets and exercise. It also helps manage type 2 diabetes by controlling blood sugar and reducing cardiovascular risks.

Noveltreat 2.4 mg (semaglutide) is a weekly, prescription-only injection used primarily for long-term weight management in adults and adolescents (12+) with obesity or overweight, often used alongside reduced-calorie diets and exercise. It also helps manage type 2 diabetes by controlling blood sugar and reducing cardiovascular risks.

Noveltreat 0.25 mg (semaglutide) is a weekly, prescription-only injection used primarily for long-term weight management in adults and adolescents (12+) with obesity or overweight, often used alongside reduced-calorie diets and exercise. It also helps manage type 2 diabetes by controlling blood sugar and reducing cardiovascular risks.

Noveltreat 1 mg (semaglutide) is a weekly, prescription-only injection used primarily for long-term weight management in adults and adolescents (12+) with obesity or overweight, often used alongside reduced-calorie diets and exercise. It also helps manage type 2 diabetes by controlling blood sugar and reducing cardiovascular risks.